文献速递糖尿病性腺与生殖内分泌

产前口服肌醇补充预防妊娠期糖尿病:一项随机对照试验

The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2017-03-21

该单中心随机对照试验纳入有糖尿病家族史的孕妇240例,从首次产检起分别给予肌醇组合(1,100 mg肌醇、27.6 mg D-手性肌醇和400 μg叶酸)或仅400 μg叶酸,在孕24至28周行口服葡萄糖耐量试验。结果显示妊娠期糖尿病发生率干预组为23.3%(n=28),对照组为18.3%(n=22),两组比较P=0.34。结论为早期妊娠开始肌醇组合未能预防有糖尿病家族史女性的妊娠期糖尿病,需进一步研究不同剂量肌醇补充是否可预防妊娠期糖尿病。

要点

  • 有糖尿病家族史孕妇中,肌醇组合组妊娠期糖尿病发生率为23.3%(n=28),对照组为18.3%(n=22),P=0.34。
  • 两组口服葡萄糖耐量试验平均空腹血糖均为81 mg/dL。
  • 早期妊娠开始肌醇组合未能预防有糖尿病家族史女性的妊娠期糖尿病。

核心结论

  • 早期妊娠开始肌醇组合未能预防有糖尿病家族史女性的妊娠期糖尿病。
  • 需进一步研究不同剂量肌醇补充是否可预防妊娠期糖尿病。

研究设计与样本

  • 随机对照试验,在单中心三级转诊中心开展,纳入有糖尿病家族史的孕妇,于首次产检时入组。
  • 共招募240名女性,每组120名,招募时间为2014年1月至2015年7月。
  • 干预组接受1,100 mg肌醇、27.6 mg D-手性肌醇和400 μg叶酸组合,对照组仅接受400 μg叶酸。
  • 所有女性在孕24至28周行口服葡萄糖耐量试验,主要终点为妊娠期糖尿病发生率。

主要发现

  • 妊娠期糖尿病发生率干预组为23.3%(n=28),对照组为18.3%(n=22),P=0.34。
  • 两组口服葡萄糖耐量试验平均空腹血糖均为81 mg/dL。
  • 两组间特征无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study investigated if inositol in a combination of myo-inositol and D-chiro-inositol would prevent gestational diabetes mellitus (GDM) in women with a family history of diabetes. RESEARCH DESIGN AND METHODS: This was a randomized controlled trial that examined whether inositol from the first antenatal visit prevents GDM. The trial was carried out in a single-center tertiary referral center. Women with a family history of diabetes were enrolled at the first antenatal visit. They were randomized to the intervention group, which received a combination of 1,100 mg myo-inositol, 27.6 mg D-chiro-inositol, and 400 μg folic acid, or to the control group, which received 400 μg folic acid only. All women had an oral glucose tolerance test between 24 and 28 weeks' gestation. The primary end point was the incidence of GDM. Statistical analysis was carried out using SPSS Statistical Package version 20. RESULTS: Two hundred forty women, 120 in each arm, were recruited between January 2014 and July 2015. There were no differences in characteristics between the groups. The incidence of GDM was 23.3% (n = 28) in the intervention group compared with 18.3% (n = 22) in the control group (P = 0.34). The mean fasting plasma glucose at the glucose tolerance test was 81 mg/dL in both groups. CONCLUSIONS: Commencing an inositol combination in early pregnancy did not prevent GDM in women with a family history of diabetes. Further studies are required to examine whether inositol supplements at varying doses may prevent GDM.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Farren M, Daly N, McKeating A, et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care. 2017. PMID: 28325784. doi:10.2337/dc16-2449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。